Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Leukemia
-
-
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
-
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
-
Sharing News from the Alliance: September Media Mentions
The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. See where the Alliance was mentioned September 2026 in…
-
Blood Cancer Awareness Month: How Alliance Clinical Trials Are Helping Improve Treatments, Early Detection and Survivorship
September is Blood Cancer Awareness Month, and the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research that advances treatments, explores earlier cancer detection, and improves the lives of people living with and beyond cancer. More than 192,000 people in the United States are expected to be diagnosed with a blood…
-
Alliance Clinical Trials Recently Activated
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials aim to improve outcomes, reduce side effects, and deliver more…
-
Recently Activated Alliance Trials
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials aim to improve outcomes, reduce side effects, and deliver more…
-
Highlighting Alliance Progress and Impact in Research through News Reports
At the Alliance for Clinical Trials in Oncology, we love sharing stories that show what’s happening in cancer research right now. Whether it’s a new clinical trial, a scientific breakthrough, or the work of one of our dedicated investigators, we want people to see the progress being made, and the real humans behind it. These…
-
Alliance Research at the 2026 AACR Symposium
The American Association for Cancer Research (AACR) Annual Meeting is often a focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship…